Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1293067C details a practical synthetic route for Spongolactone. Discover cost-effective manufacturing strategies and supply chain advantages for this potent anticancer intermediate.
Novel zinc-mediated dechlorination and Mitsunobu strategy for trans-4-(5-bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol. Enhances yield to 46.4% and reduces heavy metal reliance.
Patent CN112679477B reveals a greener route for Selinexor intermediates, offering cost reduction and supply chain reliability for API manufacturers.
Patent CN103242215A details a safer transfer hydrogenation route for Lenalidomide intermediates, offering significant cost reduction and simplified supply chain management for pharmaceutical manufacturers.
Discover a novel synthesis method for Tucatinib (CN115650977A) offering improved yield and purification. A reliable supplier solution for HER2 inhibitor intermediates.
Patent CN109776384B reveals a one-step Rh-catalyzed synthesis of complex bis-quaternary carbon oxindoles, offering significant cost reduction in API manufacturing and high atom economy.
Novel CDC25B inhibitor synthesis via microwave or base catalysis. High yield, scalable process for anti-tumor drug development and reliable supply chain.
Patent CN1563014A details novel Garcinia acid derivatives with enhanced stability and solubility for oncology. Discover cost-effective manufacturing strategies for these high-purity pharmaceutical intermediates.
Patent CN102351870B details a robust synthesis of benzacridine derivatives targeting c-myc DNA. This report analyzes cost-effective manufacturing and supply chain scalability.
Patent CN109970753B details organocatalytic synthesis of xanthone-oxindole hybrids. Offers high stereoselectivity and anti-tumor potential for drug discovery.
Patent CN102199146A details a high-yield catalytic transfer hydrogenation for Imatinib intermediates, offering superior purity and supply chain reliability for global pharmaceutical manufacturers.
Patent CN101220008B reveals a novel synthesis for ABT-263 intermediates, offering significant yield improvements and cost reduction in pharmaceutical manufacturing through catalytic oxidation.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN110835639B reveals a high-efficiency enzymatic route for producing chiral tetrahydroisoquinoline intermediates with superior stereoselectivity and scalable manufacturing potential.
Patent CN113072480A reveals a scalable chemical resolution route for chiral (-)-5-azaspiro[2.4]heptane-7-alcohol, offering superior purity and cost efficiency for API manufacturing.
Patent CN103242216A reveals a high-yield synthesis of N-Boc-hexahydro-5-oxo-cyclopenta(C)pyrrole using tetrahydrophthalimide, offering significant cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN112110951B discloses a novel aqueous radical coupling method for Bryostatin C-ring skeletons, offering cost reduction in API manufacturing and scalable production.
Advanced synthesis of indazole-triazole compounds via click chemistry for Bcr-Abl inhibition. Reliable pharma intermediate supplier offering cost-effective scale-up.
Patent CN116554134B details a novel benzofuran synthesis route offering high purity and scalable production for EGFR inhibitor pharmaceutical intermediates.
Patent CN113372270A reveals a novel Lenvatinib preparation method eliminating genotoxic impurities. Discover cost reduction in API manufacturing and high-purity supply chain solutions.